<p><strong>在本次免费网络研讨会中，深入了解早期协议决策如何直接影响供应规划和随机化及试验供应管理（RTSM）配置。与会者将学习哪些协议部分需要更深入的操作审查以及原因。特邀讲者将讨论导致下游供应问题的常见假设以及如何避免这些问题。与会者将接触到实用的问题和框架，以支持更强的研究启动基础。</strong></p>
<p>, /PRNewswire/ -- 早期协议设计决策对临床供应策略和随机化及试验供应管理（RTSM）绩效具有重要的操作性后果。许多在研究中出现的问题源于在入组开始之前做出的假设、定义或设计选择。本次网络研讨会汇集了来自 Converge、4G Clinical 和 Third Arc Bio 的专家，从多个操作角度审视这些早期决策，提供通常只有通过与经验丰富的合作伙伴直接合作才能获得的见解。</p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>www.4gclinical.com</p>
<p>以协议场景为基础，讨论将探讨设计选择如何影响预测方法、试剂盒架构、过期策略、池化模型、补给逻辑和更广泛的 RTSM 行为。通过集体分析这些因素，专家小组将揭示不同利益相关者如何解读相同的协议，最常出现的不一致之处，以及如何通过早期明确性防止下游复杂性。</p>
<p>此次讨论旨在分享专家思考，而非案例研究或产品演示。重点是高级供应专业人士、RTSM 专家和研究团队在评估新协议时始终优先考虑的实际考虑因素。与会者将更清晰地了解协议中哪些元素值得更深入的操作审查，如何避免引入风险的假设，以及促进更强跨职能对齐的问题类型。</p>
<p>会议将以简要展望新兴技术（包括人工智能工具）如何影响未来协议开发和供应规划结束。这为小组的实用指导增添了一个审慎的前瞻性视角。</p>
<p>由 4G Clinical、Converge 和一位赞助商代表共同主办的本次会议汇集了最直接影响试验准备的操作观点，为与会者提供了一个扎实而多面的视角，了解如何设计真正支持执行的协议。</p>
<p>注册参加本次网络研讨会，了解如何从操作角度评估协议，并从一开始就加强临床供应规划和 RTSM 准备。</p>
<p>加入 Jennifer Cobb Foulkes（Converge Consulting 临床供应链服务实践总监）、Jennifer Teti（Third Arc Bio 临床运营副总裁）、Savannah Holt（4G Clinical 交付运营经理）和 Jonathan Pritchard（主持人，4G Clinical 产品战略总监），参加 2026 年 2 月 11 日星期三东部时间下午 1 点（太平洋时间上午 10 点）的直播网络研讨会。</p>
<p>有关更多信息或注册此活动，请访问早期协议设计如何塑造供应策略和 RTSM 准备。</p>
<p><strong>关于 XTALKS</strong></p>
<p>Xtalks — 生命科学社区™ 赋能制药、生物技术、医疗技术、医疗保健和研究领域的专业人士，提供可信的知识和协作见解，推动行业向前发展。由 Honeycomb Worldwide Inc.提供支持，Xtalks 提供新闻、特写文章、网络研讨会、播客、视频、专家访谈、精心策划的工作机会等，旨在支持在快速发展的行业中做出明智的决策。</p>
<p>每年，成千上万的专业人士依赖 Xtalks 获取及时的信息、同行观点和行业思想领导力。加入我们的生命科学社区，保持信息灵通、互联互通，并为未来做好准备。</p>
<p>要了解有关 Xtalks 的更多信息，请访问 www.xtalks.com</p>
<p>有关与 Xtalks 合作举办网络研讨会的信息，请访问 https://xtalks.com/partner-with-us/</p>
<p>联系方式：</p>
<p>Vera Kovacevic</p>
<p>电话：+1 (416) 977-6555 x371</p>
<p>电子邮件：[email protected]</p>
<p>来源：Xtalks</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIxJk5ld3NJdGVtSWQ9Tlk2NzA2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjEwODMwUFJfTkVXU19VU1BSX19fX19OWTY3MDY0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIxJk5ld3NJdGVtSWQ9Tlk2NzA2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjEwODMwUFJfTkVXU19VU1BSX19fX19OWTY3MDY0"/></p>

<p>一场题为 “早期协议设计如何影响供应策略和随机化与试验供应管理（RTSM）准备” 的免费网络研讨会将于 2026 年 2 月 11 日下午 1 点（东部标准时间）举行。此次会议将探讨早期协议设计对临床供应策略以及随机化和试验供应管理（RTSM）的影响。来自 Converge、4G Clinical 和 Third Arc Bio 的专家将讨论运营考虑因素、导致供应问题的常见假设，以及新兴技术对未来协议开发的影响。与会者将获得有效供应规划和 RTSM 准备的见解</p>

<p><strong>In this free webinar, gain insight into how early protocol decisions directly influence supply planning and RTSM configuration. Attendees will learn which protocol sections warrant deeper operational scrutiny and why. The featured speakers will discuss common assumptions that lead to downstream supply issues and how to avoid them. Attendees will be introduced to practical questions and frameworks to support stronger study start-up foundations.</strong></p>
<div class="lb-trans"><p><strong>在本次免费网络研讨会中，深入了解早期协议决策如何直接影响供应规划和随机化及试验供应管理（RTSM）配置。与会者将学习哪些协议部分需要更深入的操作审查以及原因。特邀讲者将讨论导致下游供应问题的常见假设以及如何避免这些问题。与会者将接触到实用的问题和框架，以支持更强的研究启动基础。</strong></p>
</div><p>, /PRNewswire/ -- Early protocol design decisions carry significant operational consequences for clinical supply strategy and randomization and trial supply management (RTSM) performance. Many issues that emerge mid-study originate in assumptions, definitions or design choices made long before enrollment begins. This webinar brings together specialists from Converge, 4G Clinical and Third Arc Bio to examine these early decisions from multiple operational perspectives, offering the type of insight typically gained only through direct collaboration with experienced partners.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 早期协议设计决策对临床供应策略和随机化及试验供应管理（RTSM）绩效具有重要的操作性后果。许多在研究中出现的问题源于在入组开始之前做出的假设、定义或设计选择。本次网络研讨会汇集了来自 Converge、4G Clinical 和 Third Arc Bio 的专家，从多个操作角度审视这些早期决策，提供通常只有通过与经验丰富的合作伙伴直接合作才能获得的见解。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>www.4gclinical.com</p>
<div class="lb-trans"><p>www.4gclinical.com</p>
</div><p>Using protocol scenario as the anchor, the discussion will explore how design choices influence forecasting approaches, kit architecture, expiry strategy, pooling models, resupply logic and broader RTSM behavior. By analyzing these factors collectively, the panel will reveal how different stakeholders interpret the same protocol, where misalignment most often occurs and how early clarity can prevent downstream complications.</p>
<div class="lb-trans"><p>以协议场景为基础，讨论将探讨设计选择如何影响预测方法、试剂盒架构、过期策略、池化模型、补给逻辑和更广泛的 RTSM 行为。通过集体分析这些因素，专家小组将揭示不同利益相关者如何解读相同的协议，最常出现的不一致之处，以及如何通过早期明确性防止下游复杂性。</p>
</div><p>The conversation is designed to share expert thinking rather than case studies or product walk-throughs. The focus is on the practical considerations that senior supply professionals, RTSM specialists and study teams consistently prioritize when evaluating a new protocol. Attendees will gain a clearer sense of which elements of the protocol deserve deeper operational scrutiny, how to avoid assumptions that introduce risk and the types of questions that promote stronger cross-functional alignment from the outset.</p>
<div class="lb-trans"><p>此次讨论旨在分享专家思考，而非案例研究或产品演示。重点是高级供应专业人士、RTSM 专家和研究团队在评估新协议时始终优先考虑的实际考虑因素。与会者将更清晰地了解协议中哪些元素值得更深入的操作审查，如何避免引入风险的假设，以及促进更强跨职能对齐的问题类型。</p>
</div><p>The session will close with a brief look forward at how emerging technologies, including AI-enabled tools, may influence future protocol development and supply planning. This adds a measured horizon-scanning perspective, complementing the panel's practical guidance.</p>
<div class="lb-trans"><p>会议将以简要展望新兴技术（包括人工智能工具）如何影响未来协议开发和供应规划结束。这为小组的实用指导增添了一个审慎的前瞻性视角。</p>
</div><p>Delivered jointly by 4G Clinical, Converge and a sponsor representative, this session brings together the operational viewpoints that most directly shape trial readiness, offering attendees a grounded and multifaceted view of how to design protocols that truly support execution.</p>
<div class="lb-trans"><p>由 4G Clinical、Converge 和一位赞助商代表共同主办的本次会议汇集了最直接影响试验准备的操作观点，为与会者提供了一个扎实而多面的视角，了解如何设计真正支持执行的协议。</p>
</div><p>Register for this webinar to learn how to assess protocols through an operational lens and strengthen both clinical supply planning and RTSM readiness from the start.</p>
<div class="lb-trans"><p>注册参加本次网络研讨会，了解如何从操作角度评估协议，并从一开始就加强临床供应规划和 RTSM 准备。</p>
</div><p>Join Jennifer Cobb Foulkes, Practice Director, Clinical Supply Chain Services, Converge Consulting; Jennifer Teti, Vice President, Clinical Operations, Third Arc Bio; Savannah Holt, Delivery Operations Manager, 4G Clinical; and Jonathan Pritchard (Moderator), Director of Product Strategy, 4G Clinical, for the live webinar on Wednesday, February 11, 2026, at 1pm EST (10am PST).</p>
<div class="lb-trans"><p>加入 Jennifer Cobb Foulkes（Converge Consulting 临床供应链服务实践总监）、Jennifer Teti（Third Arc Bio 临床运营副总裁）、Savannah Holt（4G Clinical 交付运营经理）和 Jonathan Pritchard（主持人，4G Clinical 产品战略总监），参加 2026 年 2 月 11 日星期三东部时间下午 1 点（太平洋时间上午 10 点）的直播网络研讨会。</p>
</div><p>For more information, or to register for this event, visit How Early Protocol Design Shapes Supply Strategy and RTSM Readiness.</p>
<div class="lb-trans"><p>有关更多信息或注册此活动，请访问早期协议设计如何塑造供应策略和 RTSM 准备。</p>
</div><p><strong>ABOUT XTALKS</strong></p>
<div class="lb-trans"><p><strong>关于 XTALKS</strong></p>
</div><p>Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.</p>
<div class="lb-trans"><p>Xtalks — 生命科学社区™ 赋能制药、生物技术、医疗技术、医疗保健和研究领域的专业人士，提供可信的知识和协作见解，推动行业向前发展。由 Honeycomb Worldwide Inc.提供支持，Xtalks 提供新闻、特写文章、网络研讨会、播客、视频、专家访谈、精心策划的工作机会等，旨在支持在快速发展的行业中做出明智的决策。</p>
</div><p>Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.</p>
<div class="lb-trans"><p>每年，成千上万的专业人士依赖 Xtalks 获取及时的信息、同行观点和行业思想领导力。加入我们的生命科学社区，保持信息灵通、互联互通，并为未来做好准备。</p>
</div><p>To learn more about Xtalks, visit www.xtalks.com</p>
<div class="lb-trans"><p>要了解有关 Xtalks 的更多信息，请访问 www.xtalks.com</p>
</div><p>For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/</p>
<div class="lb-trans"><p>有关与 Xtalks 合作举办网络研讨会的信息，请访问 https://xtalks.com/partner-with-us/</p>
</div><p>Contact:</p>
<div class="lb-trans"><p>联系方式：</p>
</div><p>Vera Kovacevic</p>
<div class="lb-trans"><p>Vera Kovacevic</p>
</div><p>Tel: +1 (416) 977-6555 x371</p>
<div class="lb-trans"><p>电话：+1 (416) 977-6555 x371</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>电子邮件：[email protected]</p>
</div><p>SOURCE Xtalks</p>
<div class="lb-trans"><p>来源：Xtalks</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIxJk5ld3NJdGVtSWQ9Tlk2NzA2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjEwODMwUFJfTkVXU19VU1BSX19fX19OWTY3MDY0" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY67064&amp;Transmission_Id=202601210830PR_NEWS_USPR_____NY67064&amp;DateId=20260121"/></p>

Xtalks 即将举办的网络研讨会：早期协议设计如何影响供应策略和 RTSM 的准备